Introduction

Drug interactions with Tamoxifen continue to be controversial, and many people are uncertain if they are real. Most of the studies have serious flaws, however, and basing clinical decisions on these studies is problematic. In this webinar, pharmacist-philosopher Dr. Philip Hansten will lead a discussion on how to avoid three pitfalls that can interfere with the ability to manage Tamoxifen-related drug interactions.

About our speaker

Dr. Phil Hansten, PharmD is Professor Emeritus at the University of Washington in Seattle. His books on drug interactions have sold more than one million copies, and have been translated into seven languages. He has lectured widely in North America and abroad. He currently works at the intersection of science and philosophy.